The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-Chloro-N2-(2-(pyridin-2-yl)ethyl)-N4-(o-tolyl)pyrimidine-2,4-diamine ID: ALA4648038
PubChem CID: 155665861
Max Phase: Preclinical
Molecular Formula: C18H18ClN5
Molecular Weight: 339.83
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccccc1Nc1nc(NCCc2ccccn2)ncc1Cl
Standard InChI: InChI=1S/C18H18ClN5/c1-13-6-2-3-8-16(13)23-17-15(19)12-22-18(24-17)21-11-9-14-7-4-5-10-20-14/h2-8,10,12H,9,11H2,1H3,(H2,21,22,23,24)
Standard InChI Key: FETRTPMDMJBYLS-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
34.8448 -1.6509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8436 -2.4704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5517 -2.8794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.2613 -2.4699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2585 -1.6473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5499 -1.2420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9697 -2.8774 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.6768 -2.4677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3818 -2.8756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0884 -2.4666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0875 -1.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3742 -1.2412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6705 -1.6526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3819 -3.6928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9647 -1.2360 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
34.1356 -2.8784 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.4282 -2.4693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7202 -2.8773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0128 -2.4682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0182 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3117 -1.2409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6026 -1.6490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6046 -2.4704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3118 -2.8758 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
9 14 1 0
5 15 1 0
2 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 339.83Molecular Weight (Monoisotopic): 339.1251AlogP: 4.23#Rotatable Bonds: 6Polar Surface Area: 62.73Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.46CX LogP: 4.18CX LogD: 4.17Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.70Np Likeness Score: -1.97
References 1. Wang Y, Chen X, Yan Y, Zhu X, Liu M, Liu X.. (2020) Discovery and SARs of 5-Chloro-N4-phenyl-N2-(pyridin-2-yl)pyrimidine-2,4-diamine Derivatives as Oral Available and Dual CDK 6 and 9 Inhibitors with Potent Antitumor Activity., 63 (6): [PMID:32129996 ] [10.1021/acs.jmedchem.9b02121 ]